Gut health in 5 stages: what the research actually supports

A recent TikTok from Dr. Strong warns that “your gut doesn’t die overnight” and that it deteriorates in five predictable stages, with most people unaware until stage 4. The clip uses terms like “leaky gut” and “dying inside” to create urgency. But what does the scientific literature actually say about staged gut decline, and how should researchers interpret such claims?

What the clip is claiming

The video implies a linear, predictable progression of gut dysfunction—from mild irritation to full-blown systemic issues—and suggests that most individuals miss early warning signs. It frames gut health as a ticking clock, with stage 4 being a point of no return. While the creator does not specify exact biomarkers or timelines, the implication is that gut permeability (“leaky gut”) worsens in a stepwise fashion.

What the research neighborhood actually covers

Scientific literature does describe a concept of intestinal barrier dysfunction, often called “leaky gut” in lay terms. Increased intestinal permeability has been studied in conditions like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and even metabolic disorders. However, there is no consensus on a five-stage model. Research typically measures permeability via markers like zonulin, occludin, or lactulose/mannitol tests, but these are not used to stage patients into discrete categories.

Some animal and human studies suggest that chronic stress, poor diet, and dysbiosis can contribute to barrier disruption, but the progression is not uniform. Factors such as genetics, microbiome composition, and immune status vary widely. Thus, while the idea of gradual decline has some basis, the specific “5 stages” claim is an oversimplification not supported by current evidence.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey the complexity of gut physiology. It omits that many people with increased permeability are asymptomatic, and that not all permeability leads to disease. It also fails to mention that “leaky gut” is not a recognized medical diagnosis in mainstream gastroenterology, though it is a phenomenon studied in research settings.

Moreover, the clip does not discuss interventions—diet, probiotics, or pharmacological agents—that might influence gut barrier function. It also ignores that some degree of permeability is normal and necessary for nutrient absorption and immune surveillance.

How this maps to research compounds

While the clip does not mention any specific peptides, the topic of gut barrier integrity is relevant to several research peptides. For example, BPC-157 has been studied in animal models for its effects on gastrointestinal healing and intestinal anastomosis recovery. GHK-Cu is known for tissue remodeling and anti-inflammatory properties, which could theoretically support gut lining health, though direct evidence is limited. KPV (a tripeptide) has shown anti-inflammatory effects in colitis models. Selank and Semax are primarily studied for neurological effects, but their anti-inflammatory actions might indirectly affect gut-brain axis function.

It is important to note that none of these peptides are approved for treating “leaky gut” or any gastrointestinal condition. Research is preliminary, mostly in vitro or animal-based, and human data are scarce.

Research-use caveat

All peptides mentioned are intended for laboratory research use only. They are not approved for human consumption or clinical use. Researchers should handle them with appropriate safety protocols and adhere to institutional guidelines. The claims in the TikTok should not be used to justify self-experimentation.